Platelet-rich plasma to augment connective tissue healing: Making sense of it all

Journal of the American Academy of Orthopaedic Surgeons

Volumn 18, Issue 7, 2010, Pages 445-448

  Arnoczky, Steven P ^a   Caballero, Oscar ^a   Yeni, Yener N ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954920593     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201007000-00007     Document Type: Review

References (28)

1. Barrett S, Erredge S: Growth factors for chronic plantar fasciitis. Podiatry Today 2004;17(11):37-42.
2. Mishra A, Pavelko T: Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006;34(11):1774-1778. (Pubitemid 44735517)
3. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA: Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009; 37(11):2259-2272.
4. Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH: The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy 2010;26(2): 269-278.
5. Cooley J: Graft survival and the use of platelet rich plasma in hair transplantation. Available at: http:// www.regrowhair.com/hair- transplantsurgery/hair-transplant-graft-survivaland-platelet-rich-plasma/. Accessed April 13,2010.
6. Arnoczky SP, Anderson L, Fanelli G, Ho S, Mishra A, Scgalione N: The role of platelet-rich plasma in connective tissue repair. Orthopaedics Today 2009;26:29.
7. de Vos RJ, Weir A, van Schie HT, et al: Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010;303(2):144149.
8. Webber SC, Kauuffman JI: Platelet-rich fibrin matrix in arthroscopic rotator cuff repair: A prospective, randomized study. Presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons, March 9-13, New Orleans, LA.
9. Han B, Woodell-May J, Ponticiello M, Yang Z, Nimni M: The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 2009;91(6):1459-1470.
10. Visser LC, Caballero O, Arnoczky SP: Platelet-rich fibrin constructs elute higher concentrations of TGF-β1 and increase tendon cell proliferation over time when compared to blood clots: A comparative in vitro analysis. Trans Orthop Res Soc 2010;35:1208.
11. Edwards SG, Calandruccio JH: Autologous blood injections for refractory lateral epicondylitis. J. Hand Surg Am 2003;28(2):272-278.
12. Maniscalco P, Gambera D, Lunati A, et al: The "Cascade" membrane: A new PRP device for tendon ruptures. Description and case report on rotator cuff tendon. Acta Biomed 2008;79(3): 223-226.
13. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD: Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007; 177(6):575-580. (Pubitemid 47437054)
14. Bonnick SL, Beck TJ, Cosman F, Hochberg MC, Wang H, de Papp AE: DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass. Osteoporos Int 2009;20(6):911-921.
15. Cummings SR, Karpf DB, Harris F, et al: Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002;112(4):281-289. (Pubitemid 34219441)
16. Ciarelli TE, Tjhia C, Rao DS, Qiu S, Parfitt AM, Fyhrie DP: Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone 2009;45(5):903-908.
17. Donnelly E, Gladnick BP, Meredith DS, Lane JM, Boskey AL: Bisphosphonate treatment reduces cortical tissue heterogeneity in postmenopausal women with fractures. Trans Orthop Res Soc 2010;35:600.
18. Roschger P, Lombardi A, Misof BM, et al: Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the Fracture Intervention Trial Long-Term Extension (FLEX). J Bone Miner Res 2010;25(1):48-55.
19. Zoehrer R, Roschger P, Paschalis EP, et al: Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 2006;21(7):1106-1112. (Pubitemid 43962839)
20. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY: Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab 2005; 90(3):1294-1301. (Pubitemid 40463979)
21. Silva MJ, Burr DB, Nelson FR, Flynn M: On the Horizon From the ORS: How stress fractures heal. The role of the periosteum. J Am Acad Orthop Surg 2009;17:56-59.
22. Dougherty G: Quantitative CT in the measurement of bone quantity and bone quality for assessing osteoporosis. Med Eng Phys 1996;18(7):557-568.
23. Laib A, Newitt DC, Lu Y, Majumdar S: New model-independent measures of trabecular bone structure applied to in vivo high-resolution MR images. Osteoporos Int 2002;13(2):130-136. (Pubitemid 34241033)
24. Geraets WG, Van der Stelt PF, Lips P, Van Ginkel FC: The radiographic trabecular pattern of hips in patients with hip fractures and in elderly control subjects. Bone 1998;22(2):165-173. (Pubitemid 28058507)
25. Tanck E, Bakker AD, Kregting S, Cornelissen B, Klein-Nulend J, Van Rietbergen B: Predictive value of femoral head heterogeneity for fracture risk. Bone 2009;44(4):590-595.
26. McCubbrey DA, Cody DD, Peterson EL, Kuhn JL, Flynn MJ, Goldstein SA: Static and fatigue failure properties of thoracic and lumbar vertebral bodies and their relation to regional density. J Biomech 1995;28(8):891-899.
27. Lindsey DP, Kim MJ, Hannibal M, Alamin TF: The monotonie and fatigue properties of osteoporotic thoracic vertebral bodies. Spine (Phila Pa 1976) 2005;30(6):645-649.
28. Yerramshetty J, Kim DG, Yeni YN: Increased microstructural variability is associated with decreased structural strength but with increased measures of structural ductility in human vertebrae. J Biomech Eng 2009;131(9):094501- 094505.